FIS
FCPM III Services Portfolio holdings
AUM
$369M
This Quarter Return
+108.14%
1 Year Return
-29.21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$707M
AUM Growth
+$707M
(+108%)
Cap. Flow
+$43.5M
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
2
Closed
–
Top Buys
| 1 |
Dyne Therapeutics
DYN
|
$48.7M |
Top Sells
| 1 |
enGene Holdings Inc. Warrants
ENGNW
|
$5.2M |
| 2 |
Replimune Group
REPL
|
$409 |
Sector Composition
| 1 | Healthcare | 97.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
NewAmsterdam Pharma
NAMS
$2.71B
| $280M | 39.56% |
11,831,461
| – | – |
|
|
2
Dyne Therapeutics
DYN
$1.92B
| $223M | 31.49% |
7,845,364
+1,714,285
| +28% | +$48.7M |
|
|
3
enGene Holdings
ENGN
$236M
| $147M | 20.79% |
8,677,951
| – | – |
|
|
4
Replimune Group
REPL
$422M
| $39.8M | 5.62% |
4,866,449
-50
| -0% | -$409 |
|
|
5
enGene Holdings Inc. Warrants
ENGNW
$7.08M
| $15M | 2.12% |
2,878,148
-1,000,000
| -26% | -$5.2M |
|
|
ACHL
6
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| $2.99M | 0.42% |
2,390,050
| – | – |
|